1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55:181–184.
Article
2. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999; 163:94–98.
Article
3. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997; 12:133–147.
Article
4. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in parkinson's disease: a clinicopathologic study. Neurology. 1992; 42:1142–1146.
Article
5. Antonini A, Leenders KL, Vontobel P, Maguire RP, Missimer J, Psylla M, et al. Complementary pet studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and parkinson's disease. Brain. 1997; 120(Pt 12):2187–2195.
Article
6. Juh R, Kim J, Moon D, Choe B, Suh T. Different metabolic patterns analysis of parkinsonism on the 18f-fdg pet. Eur J Radiol. 2004; 51:223–233.
Article
7. Feigin A, Antonini A, Fukuda M, De Notaris R, Benti R, Pezzoli G, et al. Tc-99m ethylene cysteinate dimer spect in the differential diagnosis of parkinsonism. Mov Disord. 2002; 17:1265–1270.
Article
8. Cilia R, Marotta G, Benti R, Pezzoli G, Antonini A. Brain spect imaging in multiple system atrophy. J Neural Transm. 2005; 112:1635–1645.
Article
9. Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, et al. Brain perfusion differences between parkinson's disease and multiple system atrophy with predominant parkinsonian features. Parkinsonism Relat Disord. 2005; 11:227–232.
Article
10. Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010; 9:149–158.
Article
11. Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R. Statistical parametric mapping of (99m)tc-ecd spect in idiopathic parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med. 2004; 45:933–942.
12. Paschali A, Messinis L, Lyros E, Constantoyannis C, Kefalopoulou Z, Lakiotis V, et al. Neuropsychological functions and rcbf spect in parkinson's disease patients considered candidates for deep brain stimulation. Eur J Nucl Med Mol Imaging. 2009; 36:1851–1858.
Article
13. Firbank MJ, Molloy S, McKeith IG, Burn DJ, O'Brien JT. Longitudinal change in 99mtchmpao cerebral perfusion spect in parkinson's disease over one year. J Neurol Neurosurg Psychiatry. 2005; 76:1448–1451.
Article
14. Kimura N, Hanaki S, Masuda T, Hanaoka T, Hazama Y, Okazaki T, et al. Brain perfusion differences in parkinsonian disorders. Mov Disord. 2011; 26:2530–2537.
Article